ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 678106 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 678106; 2) Community: the network communities that were significantly associated with the response to NSC 678106; 3) Molecule: the relationships between components within communities and NSC 678106; 4) MDR: the compounds that were significantly associated with the NSC 678106.

NSC Compound Enrichment Correlation
NSC 173552 L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate 0.0321614375606955 0.11567383
NSC 3077 s-Triazine, 4,6-diamino-1-(3,4-dichlorophenyl)-1,2-dihydro-2,2-dimethyl-, monohydrochloride (8CI) 0.0321614375606955 0.069033676
NSC 349622 Cytovaricin 0.0321614375606955 -0.066904146
NSC 47468 Null 0.0321614375606955 0.2781596
NSC 63878 Cytarabine Hydrochloride AZ 0.0321614375606955 0.25991613
NSC 670805 Null 0.0321614375606955 0.072907915
NSC 294961 5-Bromo-3-(2-oxo-2-phenylethylidene)- 1,3-dihydroindol-2-one 0.0321614375606959 0.062581302
NSC 639501 Cyclopentanone, 2-pentylidene-5-[(1-piperidinyl)methyl]- hydrochloride 0.0321614375606959 0.15302969
NSC 641106 Benzenesulfonamide, N-[4-[[(4-carboxypheny)imino]methyl]- 3-methylphenyl]-N-(2-cyanoethyl)- 0.0321614375606959 0.096331555
NSC 704640 Null 0.0321614375606959 0.06927653
Total:30  Current:16    [First] [Prev] [Next] [Last]